Who owns ProQR Therapeutics?

ProQR Therapeutics is currently owned by Sofinnova Partners, through Sofinnova Capital IX, since 2018.

When did Sofinnova Partners acquire ProQR Therapeutics?

Sofinnova Partners acquired ProQR Therapeutics in 2018 (active for 8 years).

Home/Companies/Biotech/ProQR Therapeutics

ProQR Therapeutics

Biotech·

Netherlands·Active·8yr hold

ProQR Therapeutics is a healthcare / biotech company, headquartered in Netherlands.

Entry

2018

Hold

8yr

Status

Active

Est. EV

–

Investor

Sofinnova Partners

Key facts

HQNetherlands

SectorHealthcare / Biotech

Dutch biotech developing RNA-based therapies for rare genetic diseases with a focus on inherited retinal diseases.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Sofinnova Capital IX

Other portfolio companies in the same fund.

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings